Abstract B072: Is targeting ERBB2-ERBB4 heterodimers with monoclonal antibodies effective against wild-type BRAF melanomas?
Year: 2025
Type: conference-abstract
Source: Molecular Cancer Therapeutics
Authors: Victoria E. Huffman, David J. Riese, Charleigh Gumapac, Nick DeFeo, Mary Tate Reese, Allie Pegel, Markelle Scott, Teigan Nelson, Ella Wilson, Haram Kim, Angelina Shunnarah
Institution: Auburn University
Language: English
Topic: Melanoma and MAPK Pathways
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W4415444381
Cites:
Cited by:
Related to: